Skip to main content

Table 1 Analysis of the knowledge of parents and legal representatives of children who received immunoprophylaxis with palivizumab at the FHCGV from January to June of 2016 on general measures of non-drug basic care to reduce the transmissibility of HRSV

From: Incidence of respiratory syncytial virus infection in children with congenital heart disease undergoing immunoprophylaxis with palivizumab in Pará state, north region of Brazil

Preventive HRSV infection measures

n

%

Appropriated hand hygiene

80

76.9

Cleaning of hands before and after contact with the child

73

70.2

Avoid exposure of the child to passive smoking

72

69.2

Reinforcement of the child personal hygiene

71

68.3

Disinfection of contaminated surfaces

71

68.3

Limit contact with people with a respiratory infection

69

66.4

Avoid agglomerations

67

64.4

Vaccination against influenza virus

49

47.1

Total

 

66.3